Pedestrians walk past Pfizer headquarters in New York City on July 22. | Jeenah Moon/Getty Images
Vaccine science by press release has to stop.
On Monday morning, my mom sent me a text message: “Black cloud is lifting … Pfizer has a 90 percent effective vaccine.” She was one of the many people buoyed by the announcement from the drugmaker that early data suggests its Covid-19 vaccine — developed with the German biotech firm BioNTech — can prevent infection with the deadly disease.
What my mom missed, by no fault of her own, was that the news didn’t come with any detailed data, regulatory review, published study, or preprint. In fact, the trial isn’t even completed.
Instead, it was the latest instance of “science by press release” in the coronavirus pandemic.
In the race to stop the virus, drug companies, research groups, and
Upstate News Headlines
- Weekend Things to Do: Greenville South Carolina
- Man arrested after woman stabbed multiple times at SC Waffle House, deputies say
- South Carolina politicians, officials react to President Biden's inauguration, Trump presidency
- South Carolina's latest COVID-19 cases, deaths, percent positivity rate
- South Carolina Reports 3,567 New Cases as DHEC Gives COVID-19 Vaccine Update
- Lady Gaga, Jennifer Lopez and Garth Brooks perform at the inauguration
- Inaugural poet Amanda Gorman: 'Even as we grieved, we grew.'
- 'I'm just lost': Some seniors worry over lack of technology to make vaccination appointment
- Nation's first 'youth poet laureate' Amanda Gorman reads her poem at President Biden's inauguration
- Vice President Harris: A new chapter opens in US politics
- LIVE: Biden sworn in as America's 46th president, Harris becomes first female VP